These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 9547673)
1. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism. Bergman PJ; Gravitt KR; Ward NE; Beltran P; Gupta KP; O'Brian CA Invest New Drugs; 1997; 15(4):311-8. PubMed ID: 9547673 [TBL] [Abstract][Full Text] [Related]
2. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide. Gupta KP; Ward NE; Gravitt KR; Bergman PJ; O'Brian CA J Biol Chem; 1996 Jan; 271(4):2102-11. PubMed ID: 8567666 [TBL] [Abstract][Full Text] [Related]
3. An N-myristoylated protein kinase C-alpha pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate. Bergman PJ; Gravitt KR; O'Brian CA Cancer Chemother Pharmacol; 1997; 40(5):453-6. PubMed ID: 9272125 [TBL] [Abstract][Full Text] [Related]
4. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. Blobe GC; Sachs CW; Khan WA; Fabbro D; Stabel S; Wetsel WC; Obeid LM; Fine RL; Hannun YA J Biol Chem; 1993 Jan; 268(1):658-64. PubMed ID: 8093247 [TBL] [Abstract][Full Text] [Related]
5. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. Sachs CW; Safa AR; Harrison SD; Fine RL J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889 [TBL] [Abstract][Full Text] [Related]
6. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha. Cloud-Heflin BA; McMasters RA; Osborn MT; Chambers TC Eur J Biochem; 1996 Aug; 239(3):796-804. PubMed ID: 8774728 [TBL] [Abstract][Full Text] [Related]
7. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156 [TBL] [Abstract][Full Text] [Related]
8. Effects of protein kinase C modulators on multidrug resistance in human glioma cells. Matsumoto T; Tani E; Yamaura I; Miyaji K; Kaba K Neurosurgery; 1995 Mar; 36(3):565-71; discussion 572. PubMed ID: 7538636 [TBL] [Abstract][Full Text] [Related]
9. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Cleary I; Doherty G; Moran E; Clynes M Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877 [TBL] [Abstract][Full Text] [Related]
10. Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation. Beltran PJ; Fan D; Fidler IJ; O'Brian CA Biochem Pharmacol; 1997 Jan; 53(2):245-7. PubMed ID: 9037258 [TBL] [Abstract][Full Text] [Related]
11. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta. Gill PK; Gescher A; Gant TW Eur J Biochem; 2001 Aug; 268(15):4151-7. PubMed ID: 11488907 [TBL] [Abstract][Full Text] [Related]
12. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression. Chao CC FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484 [TBL] [Abstract][Full Text] [Related]
13. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. Chaudhary PM; Roninson IB J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875 [TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. Stein U; Walther W; Shoemaker RH J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016 [TBL] [Abstract][Full Text] [Related]
15. Activation of protein kinase C-alpha and translocation of the myristoylated alanine-rich C-kinase substrate correlate with phorbol ester-enhanced noradrenaline release from SH-SY5Y human neuroblastoma cells. Goodall AR; Turner NA; Walker JH; Ball SG; Vaughan PF J Neurochem; 1997 Jan; 68(1):392-401. PubMed ID: 8978751 [TBL] [Abstract][Full Text] [Related]
16. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody. Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396 [TBL] [Abstract][Full Text] [Related]
17. Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance. Stein U; Walther W; Shoemaker RH Br J Cancer; 1996 Nov; 74(9):1384-91. PubMed ID: 8912533 [TBL] [Abstract][Full Text] [Related]
18. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase Cα protects against multidrug resistance in human colon cancer cells. Lee SK; Shehzad A; Jung JC; Sonn JK; Lee JT; Park JW; Lee YS Mol Cells; 2012 Jul; 34(1):61-9. PubMed ID: 22639047 [TBL] [Abstract][Full Text] [Related]
20. Chemosensitizing multiple drug resistance of human carcinoma by Bicyclol involves attenuated p-glycoprotein, GST-P and Bcl-2. Zhu B; Liu GT; Zhao YM; Wu RS; Strada SJ Cancer Biol Ther; 2006 May; 5(5):536-43. PubMed ID: 16627975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]